This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Novoeight

Novo Nordisk A/S

Drug Names(s): N8, NN7008, NNC 0155-0000-0004, Turoctocog alfa, recombinant Factor VIII (rFVIII), Nove Eight

Description: NN7008 is a third generation recombinant factor VIII product for the treatment of hemophilia A.


Novoeight News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug